196 related articles for article (PubMed ID: 19881956)
1. The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.
Cowden Dahl KD; Dahl R; Kruichak JN; Hudson LG
Neoplasia; 2009 Nov; 11(11):1208-15. PubMed ID: 19881956
[TBL] [Abstract][Full Text] [Related]
2. MiR-125a-5p inhibits EMT of ovarian cancer cells by regulating TAZ/EGFR signaling pathway.
Cao Y; Shen T; Zhang C; Zhang QH; Zhang ZQ
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8249-8256. PubMed ID: 31646555
[TBL] [Abstract][Full Text] [Related]
3. MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression.
Yang J; Li G; Zhang K
Biomed Pharmacother; 2016 May; 80():381-387. PubMed ID: 27133078
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1.
Lee M; Kim EJ; Jeon MJ
Oncotarget; 2016 Feb; 7(8):8726-42. PubMed ID: 26646586
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.
Ying X; Wei K; Lin Z; Cui Y; Ding J; Chen Y; Xu B
Cell Physiol Biochem; 2016; 39(2):501-10. PubMed ID: 27383536
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
Ge T; Liu T; Guo L; Chen Z; Lou G
Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor-regulated miR-125a-5p--a metastatic inhibitor of lung cancer.
Wang G; Mao W; Zheng S; Ye J
FEBS J; 2009 Oct; 276(19):5571-8. PubMed ID: 19702827
[TBL] [Abstract][Full Text] [Related]
8. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z
Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723
[TBL] [Abstract][Full Text] [Related]
9. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.
Adam L; Zhong M; Choi W; Qi W; Nicoloso M; Arora A; Calin G; Wang H; Siefker-Radtke A; McConkey D; Bar-Eli M; Dinney C
Clin Cancer Res; 2009 Aug; 15(16):5060-72. PubMed ID: 19671845
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
Koutsaki M; Spandidos DA; Zaravinos A
Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
[TBL] [Abstract][Full Text] [Related]
11. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
[TBL] [Abstract][Full Text] [Related]
12. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract][Full Text] [Related]
13. LAMC2 regulated by microRNA-125a-5p accelerates the progression of ovarian cancer via activating p38 MAPK signalling.
Zhang D; Guo H; Feng W; Qiu H
Life Sci; 2019 Sep; 232():116648. PubMed ID: 31301414
[TBL] [Abstract][Full Text] [Related]
14. miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma.
Zhang M; Piao L; Datta J; Lang JC; Xie X; Teknos TN; Mapp AK; Pan Q
Mol Cancer Ther; 2015 Oct; 14(10):2313-20. PubMed ID: 26227488
[TBL] [Abstract][Full Text] [Related]
15. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
Llauradó M; Abal M; Castellví J; Cabrera S; Gil-Moreno A; Pérez-Benavente A; Colás E; Doll A; Dolcet X; Matias-Guiu X; Vazquez-Levin M; Reventós J; Ruiz A
Int J Cancer; 2012 Apr; 130(7):1532-43. PubMed ID: 21520040
[TBL] [Abstract][Full Text] [Related]
16. TET3 inhibits TGF-β1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells.
Ye Z; Li J; Han X; Hou H; Chen H; Zheng X; Lu J; Wang L; Chen W; Li X; Zhao L
J Exp Clin Cancer Res; 2016 May; 35():72. PubMed ID: 27141829
[TBL] [Abstract][Full Text] [Related]
17. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
Kitamura K; Seike M; Okano T; Matsuda K; Miyanaga A; Mizutani H; Noro R; Minegishi Y; Kubota K; Gemma A
Mol Cancer Ther; 2014 Feb; 13(2):444-53. PubMed ID: 24258346
[TBL] [Abstract][Full Text] [Related]
18. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition.
Yagi H; Yotsumoto F; Miyamoto S
Mol Cancer Ther; 2008 Oct; 7(10):3441-51. PubMed ID: 18852147
[TBL] [Abstract][Full Text] [Related]
19. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
20. miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.
Liu L; Ning Y; Yi J; Yuan J; Fang W; Lin Z; Zeng Z
Biomed Pharmacother; 2020 May; 125():109865. PubMed ID: 32058212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
